Literature DB >> 20387637

Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer.

G V Gerashchenko1, V V Gordiyuk, I Ya Skrypkina, S M Kvasha, O O Kolesnik, D D Ugryn, T V Pavlova, E R Zabarovsky, A V Rynditch, V I Kashuba.   

Abstract

DNA microarray technology comprising NotI-linking clones was used in a large-scale study of genetic and epigenetic changes in colorectal cancer. Analysis of samples from 24 patients revealed methylation, deletions, and amplifications in 137 of 181 NotI clones. For 27 genes/loci, these changes occurred in more than 30% of the tumor samples, suggesting that these genes are involved in the development of colorectal cancer. An analysis of the methylation status of CpG island of the ITGA9 gene/loci by bisulfite sequencing confirmed the NotI microarray data on the gene/loci methylation in colorectal cancer. Aberrations in 19 genes/loci were unknown previously. Their characterization may help ascertain the mechanisms responsible for colorectal cancer development and identify novel diagnostic and prognostic markers.

Entities:  

Mesh:

Year:  2009        PMID: 20387637

Source DB:  PubMed          Journal:  Ukr Biokhim Zh (1999)


  7 in total

1.  Population structure and genetic diversity in yellow catfish (Pelteobagrus fulvidraco) assessed with microsatellites.

Authors:  Wenjie Guo; Chengtao Guo; Yuhong Wang; Weihua Hu; Jie Mei
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

2.  Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.

Authors:  Luydmila A Mostovich; Tatiana Y Prudnikova; Aleksandr G Kondratov; Dina Loginova; Pavel V Vavilov; Valentina I Rykova; Sergei V Sidorov; Tatiana V Pavlova; Vladimir I Kashuba; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

3.  Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Authors:  Vera N Senchenko; Natalia P Kisseljova; Tatyana A Ivanova; Alexey A Dmitriev; George S Krasnov; Anna V Kudryavtseva; Grigory V Panasenko; Evgeny B Tsitrin; Michael I Lerman; Fyodor L Kisseljov; Vladimir I Kashuba; Eugene R Zabarovsky
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

4.  Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.

Authors:  Inessa Skrypkina; Liudmyla Tsyba; Kateryna Onyshchenko; Dmytro Morderer; Olena Kashparova; Oleksii Nikolaienko; Grigory Panasenko; Sergii Vozianov; Alina Romanenko; Alla Rynditch
Journal:  Dis Markers       Date:  2016-09-20       Impact factor: 3.434

5.  Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.

Authors:  Imran Nawaz; Li-Fu Hu; Zi-Ming Du; Khalid Moumad; Ilya Ignatyev; Tatiana V Pavlova; Vladimir Kashuba; Malin Almgren; Eugene R Zabarovsky; Ingemar Ernberg
Journal:  Oncotarget       Date:  2015-10-13

6.  Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis.

Authors:  Yue Peng; Dong Wu; Fangmei Li; Peihua Zhang; Yuandong Feng; Aili He
Journal:  Cancer Cell Int       Date:  2020-06-22       Impact factor: 5.722

7.  Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.

Authors:  Alexey A Dmitriev; Eugenia E Rosenberg; George S Krasnov; Ganna V Gerashchenko; Vasily V Gordiyuk; Tatiana V Pavlova; Anna V Kudryavtseva; Artemy D Beniaminov; Anastasia A Belova; Yuriy N Bondarenko; Rostislav O Danilets; Alexander I Glukhov; Aleksandr G Kondratov; Andrey Alexeyenko; Boris Y Alekseev; George Klein; Vera N Senchenko; Vladimir I Kashuba
Journal:  Dis Markers       Date:  2015-09-28       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.